Brexit and the Healthcare Industry – Implications for Pharma – Q2 2019

It has been over three years since the UK voted to leave the EU. After the UK and the EU agreed to a second delay to Brexit, it is due to happen on 31 October, 2019 and negotiations are still ongoing to determine the UK’s relationship with the EU after Brexit.

This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This study will be repeated in autumn this year, to gauge the changing sentiment towards Brexit from within the healthcare industry.

Scope

GlobalData’s Brexit and the Healthcare Industry – Implications for Pharma, Q2 2019 provides in-house analyst expertise on the results of a 10 minutes survey of 103 GlobalData Pharma clients and prospects which was fielded from July 2, 2019 to July 19, 2019. Participants answered questions about how they expected Brexit to affect the healthcare sector, both within and outside of the UK.

Components of the slide deck include:

  • Outcomes of Brexit – Brexit outcome on October 31, best and most likely outcomes of Brexit providing respondent mix by geography
  • Factors to Impact Healthcare—key factors to impact the post-Brexit UK healthcare industry providing respondent mix by region and seniority level as compared to previous survey waves in 2018 and 2019
  • Impact on Research and Manufacturing — key factors to impact healthcare research and manufacturing in the UK post-Brexit providing respondent mix by region and seniority level as compared to previous survey waves in 2018 and 2019
  • Impact on Corporate Strategy —level of impact of Brexit on corporate strategy providing respondent mix by region, seniority level, and headquarter location as compared to to previous survey waves in 2018 and 2019
  • Impact on Relocation — impact of Brexit on staff and headquarter relocation as indicated by resondents whose headquarters is located in the UK as compared to to previous survey waves in 2018 and 2019

Reasons to buy

Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.

Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.

Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry with quarterly surveys.

Identify emerging industry trends post-Brexit to gain a competitive advantage.

Table of Contents

1 Table of Contents (PowerPoint Deck)

1 Study Design

1.1 Abbreviations

1.2 Background, Objectives, and Design

1.3 Respondent Mix – Geography

1.4 Respondent Mix – ...

1 Table of Contents (PowerPoint Deck)

1 Study Design

1.1 Abbreviations

1.2 Background, Objectives, and Design

1.3 Respondent Mix – Geography

1.4 Respondent Mix – Seniority Level

1.5 Respondent Mix – Headquarters Location

2 Executive Summary

2.1 Key Findings

2.2 Change in Brexit Sentiment Since Previous Wave (Q4 2018/Q1 2019)

3 Overview of UK Pharma Industry

3.1 The UK Pharma Industry – A Key Driver of the UK Economy

3.2 The UK as an Attractive Location for Clinical Trials

3.3 Brexit Timeline

4 Outcomes of Brexit

4.1 Brexit Outcome on October 31, 2019

4.2 Best and Most Likely Outcomes of Brexit – No Brexit Is the Best Outcome but Not the Most Likely

4.3 Best and Most Likely Outcomes of Brexit – A Closer Look at Geography

4.4 At Least Three Years Necessary to Stabilize the UK Healthcare Industry in a “No Deal” Brexit

4.5 Why Has Your Sentiment Changed Towards Brexit? - In Their Words

5 Factors to Impact Healthcare

5.1 Key Factors to Impact the UK Healthcare Industry After Brexit

5.2 Key Factors to Impact the UK Healthcare Industry After Brexit – A Closer Look at the Top Four Factors

6 Impact on Research and Manufacturing

6.1 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? – Respondent Mix by Location

6.2 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? – Respondent Mix by Seniority Level

6.3 Why the UK Will Be an Attractive Destination for Healthcare Companies

6.4 Why the UK Will Not Be an Attractive Destination for Healthcare Companies

7 Impact on Corporate Strategy

7.1 The Impact of Brexit on Corporate Strategy

7.2 The Impact of Brexit on Corporate Strategy, by Location – A Closer Look at the Numbers

7.3 The Impact of Brexit on Corporate Strategy, by Seniority Level

7.4 How Has Brexit Most Influenced Corporate Strategy? – Investing Resources into Managing the Potential Impact of Brexit Is a Major Concern

7.5 How Has Brexit Most Influenced Corporate Strategy? – In Their Words

8 Impact on Relocation

8.1 Potential of Relocation of Staff Due to Brexit – All Respondents

8.2 Potential of Relocation of Staff Due to Brexit – A Closer Look at Geography and Seniority Level

8.3 Relocation of Headquarters Unlikely After Brexit

9 Summary of Key Findings

10 Appendix

10.1 Related and Upcoming Reports

10.3 Sources

10.4 About the Authors

10.5 About Thematic Research

10.6 About Thematic Reports

10.7 About GlobalData

10.8 Contact Us

10.9 Disclaimer

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

I truly appreciate your responsiveness and willingness to listen to our questions.

  GlaxoSmithKline Worldwide Business Development